Blueprint Medicines Corp Advanced Systemic Mastocytosis Topline Data Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Blueprint Medicines Conference Call. (Operator Instructions)
I would now like to introduce your host for this conference call, Ms. Kristin Hodous of Blueprint Medicine. You may begin.
Thank you, operator. Good morning, everyone, and welcome to Blueprint Medicines Conference Call to discuss the top line data for our EXPLORER and PATHFINDER studies in advanced SM. You can access the press release announcing the data as well as the slides that we'll be reviewing today by going to the Investors and Media section of our website at www.blueprintmedicines.com. With me on the call today are: Jeff Albers, our Chief Executive Officer; Dr. Andy Boral, our Chief Medical Officer; and Christina Rossi, our Chief Commercial Officer.
Before we get started, I would like to remind everyone that statements we make on this conference call will include
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |